AVTX

8.91

1.87% -0.17

Dopo l'orario di chiusura: 9.11 0.20 +2.24%

Avalo Therapeutics Inc (AVTX)

Panoramica Notizia Cronologia dei prezzi Financials Perché AVTX Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$9.08

Aprire:

$9.1

Volume 24 ore:

858.09K

Relative Volume:

12.38

Capitalizzazione di mercato:

$93.23M

Reddito:

$1.93M

Utile/perdita netta:

$-7.96M

Rapporto P/E:

-4.1636

EPS:

-2.14

Flusso di cassa netto:

$-36.78M

1 W Prestazione:

-3.47%

1M Prestazione:

-18.26%

6M Prestazione:

-32.81%

1 anno Prestazione:

+20,621%

Intervallo 1D:

$8.67

$9.81

Intervallo di 1 settimana:

$8.67

$9.99

Portata 52W:

$0.044

$34.46

Avalo Therapeutics Inc Stock (AVTX) Company Profile

Nome

Avalo Therapeutics Inc

Settore

Healthcare (1176)

Industria

Biotechnology (673)

Telefono

410-522-8707

Indirizzo

540 GAITHER ROAD, ROCKVILLE

Dipendente

Cinguettio

Prossima data di guadagno

2024-11-07

Ultimi documenti SEC

AVTX's Discussions on Twitter

Confronta AVTX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
AVTX Avalo Therapeutics Inc	8.91	93.23M	1.93M	-7.96M	-36.78M	-3,530.82
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-19	Iniziato	BTIG Research	Buy
2024-10-24	Iniziato	H.C. Wainwright	Neutral
2024-04-16	Aggiornamento	Oppenheimer	Perform → Outperform
2021-09-24	Iniziato	RBC Capital Mkts	Outperform

Avalo Therapeutics Inc Borsa (AVTX) Ultime notizie

02:53 AM

BTIG Research Begins Coverage on Avalo Therapeutics (NASDAQ:AVTX) - Defense World

02:53 AM

Dec 20, 2024

Avalo Therapeutics initiated with a Buy at BTIG - Yahoo Finance

Dec 20, 2024

Dec 19, 2024

BTIG optimistic on Avalo Therapeutics stock with potential for transformative Phase 2b trial results - Investing.com Canada

Dec 19, 2024

(AVTX) Trading Report - Stock Traders Daily

Dec 19, 2024

Dec 17, 2024

LUCID CAPITAL MARKETS Initiates Coverage of Avalo Therapeutics (AVTX) with Buy Recommendation - MSN

Dec 17, 2024

Dec 12, 2024

Short Interest in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Drops By 46.9% - MarketBeat

Dec 12, 2024

Dec 09, 2024

Avalo Therapeutics (AVTX) Is a Potential Hidden Gem with Significant Risk - TipRanks

Dec 09, 2024

Dec 08, 2024

Trading (AVTX) With Integrated Risk Controls - Stock Traders Daily

Dec 08, 2024

Dec 05, 2024

RA Capital Management L.P. Takes Position in Avalo Therapeutics, Inc. (NASDAQ:AVTX) - MarketBeat

Dec 05, 2024

Nov 27, 2024

Learn to Evaluate (AVTX) using the Charts - Stock Traders Daily

Nov 27, 2024

Nov 21, 2024

Avalo Therapeutics (FRA:C6K0) Cash From Other Investing Act - GuruFocus.com

Nov 21, 2024

Avalo Therapeutics (FRA:C6K0) Cyclically Adjusted PS Ratio : 0.02 (As of Nov. 21, 2024) - GuruFocus.com

Nov 21, 2024

Nov 20, 2024

REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday - MSN

Nov 20, 2024

Nov 17, 2024

(AVTX) Investment Analysis and Advice - Stock Traders Daily

Nov 17, 2024

Nov 15, 2024

Orbimed Advisors LLC Acquires New Stake in Avalo Therapeutics Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Avalo Therapeutics director June Almenoff acquires $12,749 in stock - Investing.com

Nov 14, 2024